Please login to the form below

Not currently logged in
Email:
Password:

New chair of the British Pharmacopoeia Commission

UCL's Kevin Taylor to lead body to oversee pharmaceutical standards

The UK's Department of Health (DH) has named Prof Kevin Taylor as the new chair of the British Pharmacopoeia Commission (BPC).

The BPC is the non-departmental public body responsible for updating and preparing new editions of the British Pharmacopoeia, which contains a collection of standards for medicines used in the UK.

Prof Taylor will lead a board of 17 members as it looks to update the British Pharmacopoeia, as well as the veterinary edition and the list of British Approved Names of drugs.

He is head of the department of pharmaceutics at the University College of London (UCL) School of Pharmacy.

“I am pleased to announce the appointment of Professor Taylor as the new Chair of the British Pharmacopoeia Commission,” said health minister Lord Howe.

“The Commission has a crucial job in providing authoritative official standards for pharmaceutical substances and medicinal products to researchers, scientists and industry.”

22nd October 2013

From: Regulatory, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics